PGE2, prostaglandin E2
CYP1A1 metabolism of estrogen, polyaromatic hydrocarbons, and more CYP1A2 metabolism of caffeine, duloxetine, bupropion, aflatoxin B, and more CYP2A6 metabolism of nicotine, coumarin, and more CYP2B6 metabolism of ketamine, methadone, sertraline, and more CYP2C9 metabolism of warfarin, rosuvastatin, celecoxib, and more CYP2C19 metabolism of clopidogrel, some proton pump inhibitors, more CYP2D6 metabolism of some antidepressants, antipsychotics, more CYP3A4 metabolism of half of all prescription drugs CYP2E1 metabolism of fatty acids, alcohol, and some anesthetics Phase II detoxification genes: UGT, GST, Nrf2 Phase II detoxification involves taking the metabolites of phase I and modifying them to be easily excreted through conjugation with sulfur, glutathione, glucuronic acid, amino acids, or methyl groups
Main effects Improves skin quality, elasticity, and texture
Premium Peptides For Research Purposes Only Not for Human Consumption GHK-Cu 100mg BATCH #106 Research Peptide 44.00 GHK-Cu Peptide 100mg vial Product Details: Name: GHK-Cu (Copper Tripeptide-1) CAS Number: 49557-75-7 Purity: 98% (HPLC Tested) Content: 100mg per vial Appearance: blue powder lyophilized powder Molecular Formula: C35H58N12O12Cu Molecular Weight: 757.09 g/mol Storage Instructions: Store lyophilized powder at -20C, protected from light and moisture After reconstitution, store at 28C and use within 14 days Important Information: This product is intended for laboratory research use only
